Volume 32, Issue 5 pp. 711-714
Brief Communication
Full Access

No evidence for spumavirus or oncovirus infection in relapsing–remitting multiple sclerosis

Anders Svenningsson MD

Anders Svenningsson MD

Department of Clinical Chemistry, Sahlgren's Hospital, University of Gothenburg, Gothenburg, Sweden

Search for more papers by this author
Jan Lycke MD

Jan Lycke MD

Department of Neurology, Sahlgren's Hospital, University of Gothenburg, Gothenburg, Sweden

Search for more papers by this author
Dr. Bo Svennerholm Phd

Corresponding Author

Dr. Bo Svennerholm Phd

Department of Virology, Sahlgren's Hospital, University of Gothenburg, Gothenburg, Sweden

Department of Clinical Chemistry, Sahlgren's Hospital, S-413 45 Gothenburg, SwedenSearch for more papers by this author
Simon Gronowitz PhD

Simon Gronowitz PhD

Research Unit of Replication Enzymology, University of Uppsala, Uppsala, Sweden

Search for more papers by this author
Oluf Andersen MD, PhD

Oluf Andersen MD, PhD

Department of Neurology, Sahlgren's Hospital, University of Gothenburg, Gothenburg, Sweden

Search for more papers by this author
First published: November 1992
Citations: 10

Abstract

Polymerase chain reaction analysis was used to investigate the possible role of human spumaretrovirus and oncoretroviruses (human T-cell lymphotropic virus types I {HTLV-I} and II {HTLV-II}) in multiple sclerosis. Eleven patients with relapsing-remitting multiple sclerosis in exacerbation and 11 normal blood donors were included in the study. Cerebrospinal fluid cells, peripheral blood mononuclear cells, and plasma were cocultured with allogeneic mononuclear cells for 6 weeks. Cultured cells were subjected to polymerase chain reaction analysis with primers selected for the pol and gag (human spumaretrovirus), pol and env (HTLV-I), and pol (HTLV-II) genes. Polymerase chain reaction was negative in all patient and blood donor control samples, whereas positive controls were consistently reactive with high sensitivity. No culture exhibited cytopathic effects and supernatants were negative for reverse transcriptase activity. Thus, our results do not support a role for these retroviruses in the pathogenesis of multiple sclerosis.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me